Lipoid proteinosis is an extremely rare autosomal recessive disorder that is characterized by hyaline and lipid deposits in the skin and mucous membranes. 1,2 It has also been referred to as Urbach-Wiethe disease and hyalinosis cutis et mucosae. 3 Its etiology has recently been correlated with loss-of-function mutations in the extracellular matrix protein 1 gene. [4] [5] [6] This gene is believed to play a role in skin differentiation, endochondral bone formation, and angiogenesis, as well as possessing a "biologic super-glue" function. [4] [5] [6] Although the systemic manifestations of lipoid proteinosis are myriad, they typically present on the skin and in the upper aerodigestive tract. 7 This entity is of particular relevance to otolaryngologists because affected patients commonly present with dysphonia, usually in childhood, in addition to the characteristic skin lesions. 6 A 56-year-old man presented with dysphonia and minor skin lesions. The dysphonia had been present since birth; at that time, it had manifested as a hoarse cry. The skin manifestations recurred and worsened with age in the form of discoid lesions and bead-like lesions around the patient's eyelids (moniliform blepharosis) (figure 1).
Six years earlier, the patient had sought treatment for a 1-year history of rhinorrhea, increased phlegm, and increasing hoarseness and voice weakness. He subsequently underwent two procedures on his larynx at another hospital, but he experienced no improvement.
At our evaluation, the results of a clinical examination, which included flexible nasopharyngolaryngoscopy, suggested proteinosis infiltration of the palate, uvula, and epiglottis. The airway was patent and the vocal folds were mobile. Direct laryngoscopy with the patient under general anesthesia demonstrated that the vocal folds were severely infiltrated and irregular. Following this examination, the patient reported a globus sensation in his throat, which prompted pan- Histologic examination of tissue from the uvula, nasal sinus, epiglottis, and left vocal fold identified features consistent with lipoid proteinosis. The predominant finding was the presence of perivascular deposits of hyaline eosinophilic material that were positive on periodic acid-Schiff staining (figure 3). Findings on Congo red staining for amyloid were negative. The persistence of symptoms necessitated microlaryngoscopy and laser ablations every 4 to 8 weeks. In a period of 18 months, the patient underwent 15 such procedures. He is now clinically stable, he has experienced an improvement in his voice function, and his airway is patent. He remains under regular review as an outpatient.
Lipoid proteinosis is a rare genetic disorder that usually presents in infancy or early childhood. Clinically, it typically manifests as hoarseness or a weak cry, which is indicative of laryngeal involvement. [6] [7] [8] Skin manifestations, which are not usually present at birth, are recognized to be variable within families, with the number of lesions generally increasing with age. 7,8 Bead-like lesions can appear along the rim of the eyelids; they may be accompanied by chicken pox-like scars and yellowish papules, principally involving the face and extremities. 2, 9 Fibrosis of the tongue and pharyngeal tissue may limit tongue movements and lead to speech difficulties. Lesions can occur in the nasal cavity, oropharynx, and larynx. Neuropsychiatric symptoms are variable; they include seizures, emotional lability, progressive memory loss, and psychosis. Mental retardation has been reported in one-third of patients with lipoid proteinosis. 8 Histology is required to make the diagnosis. Clinicians who are not aware of lipoid proteinosis can misdiagnose this condition as a more common entity and thus delay the correct diagnosis and appropriate treatment. 3, 4 The prognosis for patients with lipoid proteinosis is relatively good in that these patients have a normal life expectancy. 1, 2, 7 There is no proven efficacious treatment, and no gold standard of care exists because of the paucity of cases. Medical treatments have been reported to be successful only in isolated case reports; these cases featured treatment with dimethyl sulfoxide, intralesional heparin, a topical or oral steroid, or etretinate. 2, 4, 7, 10 In 1983, Harper et al reported the use of microlaryngoscopy and dissection to successfully improve an affected patient's voice. 3 In a 2011 study of children, Al Dousary and Al Anazy found that surgical intervention with direct dissection or a CO 2 laser resulted in unsatisfactory granulation tissue formation and worsened dysphonia, which necessitated multiple followup procedures. 4 They concluded that laryngeal surgical intervention should be reserved for those patients with a compromised airway, since laryngeal manifestations often abate during puberty. However, larger case series have found that microlaryngoscopy and laser excision or direct excision of deposits markedly improved voice function while obviating the need for tracheostomy in most cases. 1, 6 As mentioned, there is no accepted gold standard of management, but surgery should be used judiciously in selected patients to improve voice function and maintain the airway. Long-term follow-up and repeat procedures are usually required for disease control. Genetic counseling may also be required. 
